These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31627410)

  • 21. A Comparative Analysis of Treatment-Related Changes in the Diagnostic Biomarker Active Metalloproteinase-8 Levels in Patients with Periodontitis.
    Keskin M; Rintamarttunen J; Gülçiçek E; Räisänen IT; Gupta S; Tervahartiala T; Pätilä T; Sorsa T
    Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing of aMMP-8 point-of-care test with a modified new disease classification in Finnish adolescent cohorts.
    Heikkinen AM; Raivisto T; Räisänen I; Tervahartiala T; Bostanci N; Sorsa T
    Clin Exp Dent Res; 2022 Oct; 8(5):1142-1148. PubMed ID: 35676762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of aMMP-8 point-of-care test in indicating periodontal treatment outcomes in stage III/IV periodontitis: A 24-week follow-up study.
    Yilmaz M; Sorsa T; Demir E; Gürsoy M; Suominen A; Tervahartiala T; Räisänen IT; Gürsoy UK
    J Periodontal Res; 2023 Apr; 58(2):325-335. PubMed ID: 36618000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
    Lähteenmäki H; Umeizudike KA; Heikkinen AM; Räisänen IT; Rathnayake N; Johannsen G; Tervahartiala T; Nwhator SO; Sorsa T
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
    Sorsa T; Alassiri S; Grigoriadis A; Räisänen IT; Pärnänen P; Nwhator SO; Gieselmann DR; Sakellari D
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active MMP-8 as a Biomarker of Peri-implant Health or Disease.
    Xanthopoulou V; Räisänen I; Sorsa T; Sakellari D
    Eur J Dent; 2023 Jul; 17(3):924-928. PubMed ID: 36063841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A point-of-care test of active matrix metalloproteinase-8 predicts triggering receptor expressed on myeloid cells-1 (TREM-1) levels in saliva.
    Räisänen IT; Heikkinen AM; Pakbaznejad Esmaeili E; Tervahartiala T; Pajukanta R; Silbereisen A; Bostanci N; Sorsa T
    J Periodontol; 2020 Jan; 91(1):102-109. PubMed ID: 31343739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applicability of an active matrix metalloproteinase-8 point-of-care test in an oral and maxillofacial surgery clinic: a pilot study.
    Kallio E; Puolakkainen T; Tervahartiala T; Snäll J; Marttila E; Sorsa T; Uittamo J
    Odontology; 2024 Jan; 112(1):250-255. PubMed ID: 37249720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot Study on the Genetic Background of an Active Matrix Metalloproteinase-8 Test in Finnish Adolescents.
    Heikkinen AM; Raivisto T; Kettunen K; Kovanen L; Haukka J; Pakbaznejad Esmaeili E; Elg J; Gieselmann DR; Rathnayake N; Ruokonen H; Tervahartiala T; Sorsa T
    J Periodontol; 2017 May; 88(5):464-472. PubMed ID: 27989222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era.
    Räisänen IT; Umeizudike KA; Pärnänen P; Heikkilä P; Tervahartiala T; Nwhator SO; Grigoriadis A; Sakellari D; Sorsa T
    Med Hypotheses; 2020 Nov; 144():110276. PubMed ID: 33254580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo Regulation of Active Matrix Metalloproteinase-8 (aMMP-8) in Periodontitis: From Transcriptomics to Real-Time Online Diagnostics and Treatment Monitoring.
    Aji NRAS; Yucel-Lindberg T; Räisänen IT; Kuula H; Nieminen MT; Mc Crudden MTC; Listyarifah D; Lundmark A; Lundy FT; Gupta S; Sorsa T
    Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study.
    Yuan C; Liu X; Zheng S
    BMC Oral Health; 2018 Mar; 18(1):51. PubMed ID: 29587716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chairside Screening for Undiagnosed Diabetes and Prediabetes in Patients with Periodontitis.
    Masiero S; Alberti A; Corbella S; Francetti L
    Int J Dent; 2022; 2022():9120115. PubMed ID: 35669587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated matrix metalloproteinase-8 in saliva as diagnostic test for periodontal disease? A case-control study.
    Izadi Borujeni S; Mayer M; Eickholz P
    Med Microbiol Immunol; 2015 Dec; 204(6):665-72. PubMed ID: 25841875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Observation of Outcomes and Patient Access to Integrated Care Following Point-of-Care Glycemic Screening in Community Health Center Dental Safety Net Clinics.
    Glurich I; Berg R; Panny A; Shimpi N; Steinmetz A; Nycz G; Acharya A
    Front Oral Health; 2021; 2():670355. PubMed ID: 35048014
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis of Newly Delivered Mothers for Periodontitis with a Novel Oral-Rinse aMMP-8 Point-of-Care Test in a Rural Malawian Population.
    Leppilahti JM; Harjunmaa U; Järnstedt J; Mangani C; Hernández M; Tervahartiala T; Lopez R; Ashorn U; Ashorn P; Gieselmann DR; Sorsa T
    Diagnostics (Basel); 2018 Sep; 8(3):. PubMed ID: 30223547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. aMMP-8 Point-of-Care Test (POCT) Identifies Reliably Periodontitis in Patients with Type 2 Diabetes as well as Monitors Treatment Response.
    Heikkinen AM; Sokka TT; Torppa-Saarinen E; Pimiä E; Jokinen M; Maijala M; Rantala I; Tervahartiala T; Sorsa T; Kauppila T
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot Study on Oral Health Status as Assessed by an Active Matrix Metalloproteinase-8 Chairside Mouthrinse Test in Adolescents.
    Heikkinen AM; Nwhator SO; Rathnayake N; Mäntylä P; Vatanen P; Sorsa T
    J Periodontol; 2016 Jan; 87(1):36-40. PubMed ID: 26430926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.
    Keskin M; Lähteenmäki H; Rathnayake N; Räisänen IT; Tervahartiala T; Pärnänen P; Şenışık AM; Karaçetin D; Yentek Balkanay A; Heikkilä P; Hagström J; Rautava J; Haglund C; Gursoy UK; Silbereisen A; Bostanci N; Sorsa T
    Expert Rev Proteomics; 2020 Oct; 17(10):777-784. PubMed ID: 33406924
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic accuracy of salivary active matrix metalloproteinase (aMMP)-8 point-of-care test for detecting periodontitis in adults: A systematic review and meta-analysis.
    Wei S; Lin T; Sáenz-Ravello G; Gao H; Zhang Y; Tonetti MS; Deng K
    J Clin Periodontol; 2024 Aug; 51(8):1093-1108. PubMed ID: 38763168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.